about
Mechanisms of RNA-induced toxicity in CAG repeat disordersIdentification of variants in MBNL1 in patients with a myotonic dystrophy-like phenotypeBiological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models.Mechanistic determinants of MBNL activityAutoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript.Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.Reducing levels of toxic RNA with small moleculesMBNL proteins and their target RNAs, interaction and splicing regulation.Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.Features of modularly assembled compounds that impart bioactivity against an RNA target.Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic DystrophymiR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL.Covalent small-molecule-RNA complex formation enables cellular profiling of small-molecule-RNA interactionsBrain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.Molecular mechanisms in DM1 - a focus on foci.Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1.
P2860
Q26860030-FF8EC7D6-1A2D-4D19-9391-D83BF404C04BQ28115791-EA3D1698-804B-4A46-9C71-104B6B0E3FE6Q30377390-E211558A-187E-4A8B-A913-A0953306BC5FQ30830825-09228839-C396-42A7-906C-3B8A07E8BCDBQ33557647-9ED7DFFD-DA7C-4FB6-9909-C957DD1F06BCQ33580885-A72804AB-4FD7-4681-9A32-A5813BB3AC86Q33939836-9BABCFF1-B8D7-40EB-BA58-2DDF5B4DAD61Q34248811-F0703728-D6FF-4584-B31F-B17CE8F08D9CQ34786164-07EDCB84-DF74-4BAE-9E33-7890CB4D3E07Q34986416-6A4E08F9-AB2B-4D9B-9E2B-940C458BBA75Q36146964-80C5EDA8-BB69-4496-BAA9-787EF4776001Q36667023-7BF40A74-227C-4D0B-90E2-C8C2DE6C0F3DQ37421427-0A30F1F9-3A69-4A15-A3C5-DB88076E5D83Q38177257-1BE5E09D-4F93-4DB5-B48F-DE23CA5E887CQ38326275-B2438E42-7093-4FD1-9D3E-FF6D5176CC2CQ41092886-E39FFEC9-3511-4E0D-A93F-4004EBE11E7AQ45822517-A5D8D813-9797-4689-A1E2-DF9C5536FEE8
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
RNA splicing is responsive to MBNL1 dose
@ast
RNA splicing is responsive to MBNL1 dose
@en
RNA splicing is responsive to MBNL1 dose
@nl
type
label
RNA splicing is responsive to MBNL1 dose
@ast
RNA splicing is responsive to MBNL1 dose
@en
RNA splicing is responsive to MBNL1 dose
@nl
prefLabel
RNA splicing is responsive to MBNL1 dose
@ast
RNA splicing is responsive to MBNL1 dose
@en
RNA splicing is responsive to MBNL1 dose
@nl
P2093
P2860
P1433
P1476
RNA splicing is responsive to MBNL1 dose
@en
P2093
Lucio Comai
Sharan Paul
Sita Reddy
Sonali P Jog
Stephanie Tring
Warunee Dansithong
P2860
P304
P356
10.1371/JOURNAL.PONE.0048825
P407
P577
2012-11-15T00:00:00Z